Compare Aurora Drug Discovery vs. Profluent

Aurora utilizes principles of quantum mechanics and thermodynamics alongside a sophisticated continuous water model to assess the solvation effects on ligand binding affinities. This methodology is significantly different from the traditional scoring functions typically employed for predicting binding affinities. By integrating entropy and aqueous electrostatic contributions directly into the computations, Aurora's algorithms yield far more precise and reliable binding free energy values. The interaction between a ligand and a protein is fundamentally defined by the binding free energy value. This free energy (F) serves as a thermodynamic measure that correlates directly with the experimentally determined inhibition constant (IC50), influenced by factors such as electrostatic interactions, quantum effects, aqueous solvation forces, and the statistical characteristics of the molecules involved. Non-additivity in F arises primarily from two key components: the electrostatic and solvation energy, and the entropy, which together contribute to the complexity of ligand-protein interactions. Understanding these contributions is essential for the accurate prediction of binding affinities in drug design and molecular biology.

Profluent's innovative platform transforms the field of protein design by seamlessly combining cutting-edge AI technology with its own experimental capabilities, allowing for the development of proteins that are either inspired by nature or entirely newly conceived. This comprehensive methodology provides precise, flexible, and scalable solutions to intricate biological problems, resulting in advancements that push the boundaries of protein functionality. Profluent's foundational models extend protein design beyond the constraints of traditional random approaches, enabling the simultaneous optimization of various characteristics, enhancing sequence diversity, and unlocking new functionalities. By venturing into unexplored protein territories, Profluent presents distinctive opportunities that surpass the limitations of natural or patented proteins, streamlining the process for partners to achieve commercial viability in a more cost-effective and accessible manner. Underpinning Profluent's capabilities is a strong dedication to scientific excellence, utilizing a wide range of datasets and advanced AI techniques to address complex challenges effectively. As a result, Profluent not only advances protein engineering but also sets a new standard in the industry, fostering innovative collaborations and breakthroughs.